Dutosme, Herminia S.

HRN: 01-03-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2024
05/08/2024
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: